Europe Autoimmune Disease Therapeutics Market By Indication (Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications) By Drug Class (Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs Nonsteroidal anti-inflammatory drugs, Interferons and Other Drugs) By the Distribution Channel (Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores)

Analysis of Market Size & Trends

The Europe Autoimmune Disease Therapeutics Market would witness market growth of 3.94% CAGR during the forecast period (2019-2025).

Epigenetic pathways play a key role in the growth and function of the immune system. A growing body of research has been released over the past century attempting to clarify the correlation between epigenetic modifications and the growth of autoimmune disorders. Epigenetic changes like histone modifications, DNA methylation, and non-coding RNAs, are primarily engaged in the pathogenesis of autoimmune diseases by controlling gene expression. Significant epigenetic changes have occurred during the growth of the most common human autoimmune diseases. These changes include systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjogren's syndrome (SS), autoimmune thyroid illnesses (AITD), and type 1 diabetes (T1D). These targeted at offering fresh insights into the pathogenesis of autoimmune diseases and the chance of developing new therapeutic strategies that target the epigenome.

Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Click Here For Free Insights

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.

Scope of the Autoimmune Disease Therapeutics Market Analysis

Market Segmentation:

By Indication

• Rheumatic Disease
• Diabetes
• Multiple Sclerosis
• Inflammatory Bowel Disease
• Other Indications

By Drug Class

• Anti-Inflammatory
• Anti-Hyperglycemics
• NSAIDs
• Interferons
• Other Drugs

By Distribution Channel

• Hospital Pharmacy
• Online
• Retail Pharmacies and Drug Stores

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Companies Profiled

• ABBOTT Laboratories
• Bio-Rad Laboratories, Inc.
• Johnson and Johnson
• GlaxoSmithKline PLC (GSK)
• Pfizer, Inc.
• Merck & Co., Inc.
• Bayer AG
• AbbVie, Inc.
• Amgen, Inc.
• Novartis AG